# Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

> **NCT04821141** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Kansas Medical Center** · enrollment: 120 (estimated)

## Conditions studied

- Risk Reduction
- Breast Cancer

## Interventions

- **DRUG:** Bazedoxifene and Conjugated Estrogens

## Key facts

- **NCT ID:** NCT04821141
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-14
- **Primary completion:** 2026-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04821141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04821141, "Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04821141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*